Detection of late responders from nonresponders to apremilast by simply measuring pruritus at week 4: Results from a prospective cohort observational study

J Am Acad Dermatol. 2024 Sep;91(3):547-549. doi: 10.1016/j.jaad.2024.05.015. Epub 2024 May 14.
No abstract available

Keywords: Th17; Th2; apremilast; cytokine; pruritus; psoriasis; responder.

Publication types

  • Observational Study
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Pruritus* / diagnosis
  • Pruritus* / drug therapy
  • Pruritus* / etiology
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Thalidomide* / analogs & derivatives
  • Thalidomide* / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • apremilast
  • Thalidomide
  • Anti-Inflammatory Agents, Non-Steroidal